Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Biotech
Genentech axes $3B Adaptimmune cell therapy deal
In the same week that Genentech confirmed it's cutting staffers, the company has terminated a cell therapy partnership with Adaptimmune Therapeutics.
Gabrielle Masson
Apr 12, 2024 11:22am
Poseida examines CAR-T conditioning to crack into solid tumors
Apr 10, 2024 10:32am
After knock back, BrainStorm aligns with FDA on ph. 3 ALS trial
Apr 9, 2024 7:51am
Ex-bluebird execs hope to fly startup to delivery tech heights
Apr 9, 2024 7:00am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
Ring's new human viral vector delivers gene to retinas of mice
Apr 2, 2024 8:10am
More News
Ginkgo loads up Modulus CAR assets, latest in a string of deals
Apr 2, 2024 7:01am
Verve halts VERVE-101 enrollment, focuses on 2nd PCSK9 editor
Apr 2, 2024 7:00am
Carisma lightens load to stretch cash runway into Q3 2025
Apr 1, 2024 11:08pm
Gamida accepts sale to investment firm to survive
Mar 27, 2024 9:53am
See more stories